Uncommon
PrivateLast Round
Series A
Jun 9, 2023
Total Funding Raised
$33.77M
Company Overview
Uncommon is a biotechnology company that developed RNA-based technology for cultivated meat production before pivoting to focus on programmable RNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
RNA therapeuticsSymphoRNAdrug discoverynucleic acid deliverybiotech R&DRNA medicineAI-augmented drug designbiotech platformcultivated meatlab-grown meatfood techbiotech licensingRNA foundation modelsdrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Uncommon Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Uncommon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 9, 2023 | ||||
| Grant | Feb 1, 2021 | ||||
| Seed | Jan 1, 2020 | ||||
| Pre Seed | Nov 1, 2018 |
Uncommon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| East Alpha | Series A |
| Lowercarbon Capital | Series A |
| Balderton Capital | Series A |
| Redalpine | Series A |
Uncommon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Uncommon's valuation, stock price, and market status.
Firmographic Details
HeadquartersCambridge
Employee Range8
Year Founded2017
Last FundingJun 9, 2023